市場調查報告書
商品編碼
1535299
生物醫藥品加工設備與消耗品的到市場規模,佔有率,預測,各產品類型,各用途,趨勢分析-2031年前的全球預測Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type, Application - Global Forecast to 2031 |
生物製藥加工設備和耗材市場:按產品類型(過濾、色譜、生物反應器、細胞培養基、搖床、服務)、按應用(疫苗、單株抗體、研發)- 到2031 年的市場規模、佔有率、預測、趨勢分析
2023年全球生物製藥加工設備及耗材市場價值363.8億美元。該市場預計將從 2024 年的 402.2 億美元增至 2031 年的 757.2 億美元,2024-2031 年預測期間複合年增長率為 9.5%。
經過廣泛的二次和初步研究以及對市場情景的深入分析,本報告確定了關鍵的行業驅動因素、限制因素、挑戰和機會。該市場的成長將受到生物製藥市場的成長、生物製藥廠產能擴張以及一次性生物加工設備的採用增加的推動。此外,新興國家、向生物加工 4.0 的轉變以及個人化藥物的日益普及預計將為該市場的利益相關者提供成長機會。
本報告包??含的競爭格局是基於對過去三年(2021-2024 年)市場參與者所採用的關鍵策略發展的廣泛評估。全球生物製藥加工設備和耗材市場報告中介紹的主要公司包括3M 公司(美國)、Bio-Rad Laboratories, Inc(美國)、賽默飛世爾科技公司(美國)、丹納赫公司(美國)、安捷倫科技公司(美國) )、Repligen Corporation(美國)、Sartorius AG(德國)、Merck KGaA(德國)、Eppendorf AG(德國)和 Solaris Biotechnology Srl(義大利)。
Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type (Filtration, Chromatography, Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D)-Forecast to 2031
The global biopharmaceutical processing equipment and consumables market was valued at $36.38 billion in 2023. This market is expected to reach $75.72 billion by 2031 from an estimated $40.22 billion in 2024, at a CAGR of 9.5% during the forecast period of 2024-2031.
After extensive secondary and primary research and in-depth analysis of the market scenario, the report identifies the key industry drivers, restraints, challenges, and opportunities. This market's growth is driven by the growing biopharmaceuticals market, biopharmaceutical plant capacity expansions, and the rising adoption of single-use bioprocessing equipment. Furthermore, emerging economies, the shift toward Bioprocessing 4.0, and the rising adoption of personalized medicines are expected to generate growth opportunities for the stakeholders in this market.
The report includes a competitive landscape based on an extensive assessment of the key strategic developments that led market participants to adopt over the past three years (2021-2024). The key players profiled in the global biopharmaceutical processing equipment and consumables market report are 3M Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).
Based on product type, the filtration systems segment is estimated to account for the largest share of the market in 2024, at 22.3%. The filtration systems are used repeatedly at every stage of the bioprocessing process, and their technological developments and repeatability are the main reasons contributing to the highest share. The development of single-use filtration systems and enhanced filtration titers are the primary areas of technological innovation in filtration.
Based on application, the market is segmented into commercial bioproduction and research bioproduction. In 2024, The commercial bioproduction segment is estimated to account for the larger share of 77.5% of the global biopharmaceutical processing equipment and consumables market to meet the growing demand for biopharmaceuticals. Biopharmaceutical companies are expanding their production capacities, developing new facilities, and moving to emerging biopharmaceutical hubs like India and Singapore, further accelerating the demand for biopharmaceutical processing equipment.
Based on end user, the global biopharmaceutical processing equipment and consumables market is categorized into pharmaceutical & biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and academic & research institutes. The biopharmaceutical processing equipment and consumables market is expected to be dominated by the pharmaceutical & biopharmaceutical firms sector by 2024. The growing demand for biopharmaceutical goods has led to a notable surge in growth for pharmaceutical and biopharmaceutical companies in recent times, with the latter holding the biggest part of the market. The largest share of the market is also supported by initiatives taken by governments in various nations, which include funding and grants to pharmaceutical and biopharmaceutical companies for the production and R&D of biopharmaceuticals and an increase in facility expansion by major players.
An in-depth analysis of the geographical scenario of the biopharmaceutical processing equipment and consumables market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa) and covers major countries in each region.
In 2024, Europe is estimated to command the largest share of the 33.5% biopharmaceutical processing equipment and consumables market, followed by North America, Asia-Pacific, Latin America, and Middle East & Africa. The availability of top producers of consumables and equipment for biopharmaceutical processing, rising drug sales, encouragement from regulatory and governmental bodies to use biopharmaceuticals for a range of medical conditions, and a number of businesses growing both their production and operational capabilities.
Global Biopharmaceutical Processing Equipment and Consumables Market, by Product Type
Note: Other equipment and consumables include membrane adsorbers, cell disruption reagents, pipettes, syringes, vials, closures, tubing, connectors, and sensors.
Global Biopharmaceutical Processing Equipment and Consumables Market, by Application
Global Biopharmaceutical Processing Equipment and Consumables Market, by End User
Global Biopharmaceutical Processing Equipment and Consumables Market, by Geography